<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00508963</url>
  </required_header>
  <id_info>
    <org_study_id>UCSF Infectious Diseases</org_study_id>
    <nct_id>NCT00508963</nct_id>
  </id_info>
  <brief_title>Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis</brief_title>
  <official_title>Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <brief_summary>
    <textblock>
      Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be
      treated with sodium stibogluconate (Pentostam).
    </textblock>
  </brief_summary>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <condition>Leishmaniasis, Cutaneous</condition>
  <condition>Leishmaniasis, Mucocutaneous</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium stibogluconate (Pentostam)</intervention_name>
    <description>20 mg/kg IV every day for 20 or 28 days</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy proven new world cutaneous or mucocutaneous leishmania

        Exclusion Criteria:

          -  Prolonged QT

          -  Liver disease

          -  Pancreatitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Brian Schwartz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of CA at San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kanade Shinkai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of CA at San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jane E Koehler, MA, MD</last_name>
    <phone>415-476-3536</phone>
    <email>jkoehler@medicine.ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of CA at San Francisco Hospitals and Clinics</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2007</study_first_submitted>
  <study_first_submitted_qc>July 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2007</study_first_posted>
  <last_update_submitted>December 12, 2014</last_update_submitted>
  <last_update_submitted_qc>December 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>New World Cutaneous or Mucocutaneous Leishmaniasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leishmaniasis</mesh_term>
    <mesh_term>Leishmaniasis, Cutaneous</mesh_term>
    <mesh_term>Leishmaniasis, Mucocutaneous</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antimony Sodium Gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

